Профилактическое средство пролонгированного действия при инфаркте миокарда на основе нитроглицерина и ацетилсалициловой кислоты
Închide
Articolul precedent
Articolul urmator
291 1
Ultima descărcare din IBN:
2022-05-27 10:50
Căutarea după subiecte
similare conform CZU
615.22:616.127-005.8 (1)
Medicamentele potrivit acţiunii lor principale (395)
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (975)
SM ISO690:2012
ТОДОРОВА, Юлия. Профилактическое средство пролонгированного действия при инфаркте миокарда на основе нитроглицерина и ацетилсалициловой кислоты. In: Analele ştiinţifice ale Universităţii de Stat din Moldova: . Științe ale naturii și exacte. Științe economice, 14 septembrie 2021, Chişinău. Chișinău, Republica Moldova: Centrul Editorial-Poligrafic al USM, 2021, SNE, SE, pp. 27-31. ISBN 978-9975-142-54-0.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Analele ştiinţifice ale Universităţii de Stat din Moldova
SNE, SE, 2021
Conferința "Analele ştiinţifice ale Universităţii de Stat din Moldova"
Chişinău, Moldova, 14 septembrie 2021

Профилактическое средство пролонгированного действия при инфаркте миокарда на основе нитроглицерина и ацетилсалициловой кислоты

CZU: 615.22:616.127-005.8

Pag. 27-31

Тодорова Юлия
 
Молдавский Государственный Университет
 
 
Disponibil în IBN: 23 februarie 2022


Rezumat

The purpose of master's thesis on the topic: "Nitroglycerin and acetylsalicylic acid a preventive remedy of prolonged action in case of heart attack" was to elaborate a formulation of a new prophylactic agent of prolonged action for myocardial infarction based on nitroglycerin and acetylsalicylic acid. The proposed drug will be effective for the relief and systematic prevention of angina attacks, which can develop into myocardial infarction, and also as a rehabilitation treatment after myocardial infarction. Acetylsalicylic acid was obtained in laboratory conditions by two methods. The active and auxiliary components of the potential drug were subjected to chemical and pharmaceutical analyzes. After fabrication the dosage form, it was also subject to quality control, in accordance with the requirements of the current regulatory and technical documentation. The proofs of the prolonged effect of the dosage form are presented.